Personalized Health Project

Expert Panel for White Paper

Thanks to the expert panel that provided input for this study and reviewed the final draft. The panel of thirty-six life science leaders was chosen to represent a wide range of specialists, stakeholders, critics, and points of view.

Adam Gazzaley, MD, PhD, neurologist and neuroscientist, University of California at San Francisco

Anthony Atala, MD, board member, Regenerative Medicine Foundation; director, Wake Forest Institute for Regenerative Medicine

Arthur Caplan, PhD, bioethicist, University of Pennsylvania

Atul Butte, MD, PhD, geneticist and bioinformaticist, Stanford University Medical School

Brook Byers, MBA, venture capitalist, Kleiner Perkins Caufield & Byers

Christopher Austin, MD, neurologist; director, Chemical Genomics Center, National Institutes of Health

Daniel Kraft, MD, PhD, oncologist; stem cell researcher, Stanford University Medical School

David Agus, MD, oncologist, proteomics researcher, entrepreneur, University of Southern California; co-founder, Navigenics

David Ewing Duncan, journalist and life science policy analyst; director, The Center for Life Science Policy, University of California at Berkeley

Dietrich Stephan PhD, geneticist; founder and director, Institute for Individualized Health (IGNITE); cofounder, Navigenics; director, The Gene Partnership, Harvard Medical School

Edward Abrahams, PhD, president, Personalized Medicine Coalition

Eric Schadt, PhD, biocomputationist; chief scientific officer, Pacific Biosciences; cofounder, Sage Bionetworks

Eric Topol, MD, cardiologist and translational geneticist; director, Scripps Translational Science Institute

Frank L. Douglas, MD, PhD, president and CEO, Austen BioInnovation Institute in Akron, Ohio; founder and first executive director of the MIT Center for Biomedical Innovation, Massachusetts Institute of Technology; former chief scientific officer, Aventis

Frederick Frank, MBA, life sciences investment banker; vice chairman, Peter J. Solomon Company; former vice chairman, Lehman Brothers

George Church, PhD, molecular biologist, professor of genetics, and director, Center for Computational Genetics, Harvard Medical School

George Poste, PhD, researcher, policy analyst, and former pharmaceutical executive; chief scientist, Complex Adaptive Systems Initiative; professor of Health Innovation, Arizona State University; former president, R&D, SmithKline Beecham

Greg Simon, JD, senior vice president for worldwide policy, Pfizer; former president, Faster Cures; former chief domestic policy advisor to Vice President Al Gore

Gregory Stock, PhD, MBA, founding CEO, Signum Biosciences; founding director, Program on Medicine, Technology and Society, University of California at Los Angeles School of Medicine

Hank Greely, JD, professor of law, Stanford University; director, Center for Law and the Biosciences

James Heywood, cofounder and chairman, PatientsLikeMe

James Thomson, VMD, PhD, stem cell scientist; director of Regenerative Biology, The Morgridge Institute for Research, University of Wisconsin School of Medicine and Public Health

Joshua Adler, MD, physician, chief medical officer, University of California at San Francisco Medical Center

Lee Hood, MD, PhD, molecular biologist and bioinformaticist; founder and director, Institute for Systems Biology

Linda K. Molnar, PhD, entrepreneur, personalized medicine and nanotechnology expert; founding principal, LKM Strategic Consulting

Margaret Anderson, executive director, FasterCures

Martyn Smith, PhD, professor of toxicology, School of Public Health, Division of Environmental Health Sciences, University of California at Berkeley

Michael Roizen, MD, preventive medicine; director, Wellness Institute, Cleveland Clinic

Misha Angrist, PhD, assistant professor, Duke University Institute for Genome Sciences & Policy

Nathaniel David, PhD, entrepreneur and venture capitalist; venture partner, Arch Venture Partners

Paul Billings, MD, PhD, clinical geneticist; chief medical officer, Life Technologies

Ray Woosley, MD, PhD, president and CEO, Critical Path Institute

Safi Bahcall, PhD, entrepreneur; CEO, Synta Pharmaceuticals Corp.

Stephen Friend, MD, PhD, president, CEO, cofounder, Sage Bionetworks; former senior vice president and franchise head for Oncology Research, Merck

Stephen P. Spielberg, MD, PhD, pediatrician; director, Center for Personalized Medicine and Therapeutic Innovation, Children‘s Mercy Hospital, Kansas City, Mo.; former dean, Dartmouth Medical School

Steve Wiggins, venture capitalist and former health insurance executive; managing director of Essex Woodlands Health Ventures; founder and former CEO, Oxford Health Plans

Zack Lynch, entrepreneur; executive director, Neurotechnology Industry Organization